At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
Pacing Lead (Model 4296 LV Lead)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Model 4296 Left Ventricular Lead Study
In Brief
A clinical study evaluating Pacing Lead (Model 4296 LV Lead) for Heart Failure. Completed, enrolled 90 participants across 16 sites in 8 countries.
Detailed Summary
This study is designed to show that a new lead, which paces the left bottom chamber (left ventricle) of the heart, is safe. Using a lead on the left side of the heart has been shown to potentially improve heart failure symptoms. The shape and size of this new lead may make it a good choice for patients or physicians.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesAustria, Finland, Germany, India, Italy, Netherlands, Norway, Slovakia
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedJun 2009
Primary CompletionDec 2009
Study CompletionFeb 2010
TodayJul 2026
First PostedJun 24, 2009
Enrollment StartJun 1, 2009
Primary CompletionDec 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.0 years ago
Interventions
Pacing Lead (Model 4296 LV Lead)device
Implant and follow-up of study device